Scholarlink

<p>Ambulatory specialized medical care (ASV) is an innovative care model that enables specialists from hospitals and private practices to provide outpatient treatment within interdisciplinary and cross-sectoral teams under a&#xa0;uniform regulatory framework regarding access, quality, and reimbursement. After a&#xa0;slow start, participation in the ASV model has increased significantly, and it has become an established component of healthcare in terms of approved teams, participating physicians, and treated patients. It is the only area of care within the German Social Code, Book&#xa0;V (SGB&#xa0;V), in which cross-sectoral collaboration in hemato-oncology is explicitly mandated by law and participation in interdisciplinary tumor conferences is required and reimbursed. However, the legislator’s objectives—such as reducing barriers to access, minimizing regional disparities, and ensuring continuity of care—have not yet been fully achieved. The main challenge is that the ASV model is designed from the perspective of providers and health insurers rather than being constructed based on the patient’s care pathway, and it is insufficiently aligned with adjacent care structures. This results in interface problems and gaps in care. This article presents current data on service provision, identifies existing challenges, and discusses potential solutions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sektorenübergreifende interdisziplinäre Versorgung in der Onkologie

  • 期刊论文

  • 发表日期：

    2026年1月21日

查看全文
  • Robert Dengler,
  • Sonja Froschauer

摘要

Ambulatory specialized medical care (ASV) is an innovative care model that enables specialists from hospitals and private practices to provide outpatient treatment within interdisciplinary and cross-sectoral teams under a uniform regulatory framework regarding access, quality, and reimbursement. After a slow start, participation in the ASV model has increased significantly, and it has become an established component of healthcare in terms of approved teams, participating physicians, and treated patients. It is the only area of care within the German Social Code, Book V (SGB V), in which cross-sectoral collaboration in hemato-oncology is explicitly mandated by law and participation in interdisciplinary tumor conferences is required and reimbursed. However, the legislator’s objectives—such as reducing barriers to access, minimizing regional disparities, and ensuring continuity of care—have not yet been fully achieved. The main challenge is that the ASV model is designed from the perspective of providers and health insurers rather than being constructed based on the patient’s care pathway, and it is insufficiently aligned with adjacent care structures. This results in interface problems and gaps in care. This article presents current data on service provision, identifies existing challenges, and discusses potential solutions.